BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 30317667)

  • 1. Essential TNM: a registry tool to reduce gaps in cancer staging information.
    Piñeros M; Parkin DM; Ward K; Chokunonga E; Ervik M; Farrugia H; Gospodarowicz M; O'Sullivan B; Soerjomataram I; Swaminathan R; Znaor A; Bray F; Brierley J
    Lancet Oncol; 2019 Feb; 20(2):e103-e111. PubMed ID: 30712797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing information on stage at diagnosis of cancer in Africa.
    Parkin DM; Liu B; Adoubi I; Makouanzi AS; Masalu N; Mrema C; Ndlovu N; Omonisi A; Traore B; Joko-Fru Y
    Acta Oncol; 2023 Apr; 62(4):335-341. PubMed ID: 37102435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CanStaging+: an electronic staging tool for population-based cancer registries.
    Soerjomataram I; Ervik M; Fox C; Hawkins S; Yeung K; Napolitano G; Tittenbrun Z; Bray F; Gavin A
    Lancet Oncol; 2021 Aug; 22(8):1069. PubMed ID: 34339643
    [No Abstract]   [Full Text] [Related]  

  • 4. How many Italian cancer patients are eligible for, and may respond to, Italian Medicines Agency-approved immune checkpoint inhibitors?
    Crocetti E; Ravaioli A; Falcini F; Vattiato R; Mancini S; Baldacchini F; Zamagni F; Vitali B; Balducci C; Bucchi L; Giuliani O
    Tumori; 2024 Apr; 110(2):109-115. PubMed ID: 38372036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
    Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
    Front Immunol; 2022; 13():967277. PubMed ID: 36466837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based validation study of the 8th edition UICC/AJCC TNM staging system for cutaneous melanoma.
    Hynes MC; Nguyen P; Groome PA; Asai Y; Mavor ME; Baetz TD; Hanna TP
    BMC Cancer; 2022 Jul; 22(1):720. PubMed ID: 35778691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune checkpoint inhibitors in adjuvant setting after radical resection of melanoma: a meta-analysis of the pivotal trials.
    Bersanelli M; Petrelli F; Buti S; Stanganelli I
    Hum Vaccin Immunother; 2022 May; 18(3):1902723. PubMed ID: 33881961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts.
    Garbe C; Keim U; Suciu S; Amaral T; Eigentler TK; Gesierich A; Hauschild A; Heinzerling L; Kiecker F; Schadendorf D; Stadler R; Sunderkötter C; Tüting T; Utikal J; Wollina U; Zouboulis CC; Keilholz U; Testori A; Martus P; Leiter U; Eggermont AMM;
    J Clin Oncol; 2020 Aug; 38(22):2543-2551. PubMed ID: 32530760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage.
    Teterycz P; Ługowska I; Koseła-Paterczyk H; Rutkowski P
    World J Surg Oncol; 2019 Jul; 17(1):129. PubMed ID: 31345228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new 8th edition of TNM staging and its implications for skin cancer: a review by the British Association of Dermatologists and the Royal College of Pathologists, U.K.
    Keohane SG; Proby CM; Newlands C; Motley RJ; Nasr I; Mohd Mustapa MF; ; Slater DN;
    Br J Dermatol; 2018 Oct; 179(4):824-828. PubMed ID: 29923189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New TNM melanoma staging system: linking biology and natural history to clinical outcomes.
    Balch CM; Buzaid AC; Soong SJ; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
    Semin Surg Oncol; 2003; 21(1):43-52. PubMed ID: 12923915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the agreement between TNM 7th and 8th in a population-based series of cutaneous melanoma.
    Crocetti E; Stanganelli I; Mancini S; Vattiato R; Giuliani O; Ravaioli A; Balducci C; Falcini F; Pimpinelli N
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):521-524. PubMed ID: 30317667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study.
    Verver D; Louwman WJ; Koljenović S; Verhoef C; Grünhagen DJ; van Akkooi ACJ
    Eur J Cancer; 2018 Mar; 92():100-107. PubMed ID: 29217356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden.
    Isaksson K; Katsarelias D; Mikiver R; Carneiro A; Ny L; Olofsson Bagge R
    Ann Surg Oncol; 2019 Sep; 26(9):2839-2845. PubMed ID: 31111349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How staging of thin melanoma is changed after the introduction of TNM 7th edition: a population-based analysis.
    Caldarella A; Fancelli L; Manneschi G; Chiarugi A; Nardini P; Crocetti E
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):73-6. PubMed ID: 26113451
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.